Tesamorelin 10mg - single vial

Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog that stimulates the pituitary gland to increase natural growth hormone (GH) production and subsequent IGF-1 levels. It is best known for its ability to reduce visceral abdominal fat while preserving lean muscle mass. Unlike exogenous growth hormone, Tesamorelin works by enhancing the body's natural GH pulse patterns, making it a popular research peptide for body composition, recovery, and metabolic health.

Common Research Dosing Protocol:

• 1-2 mg daily

• Most common protocol: 2 mg daily

• Administered 5-7 days per week

• Typical cycle length: 12-26 weeks

Administration:

• Subcutaneous injection

• Best administered on an empty stomach

• Common timing: 30-60 minutes before bed or first thing in the morning

• Avoid eating for approximately 30-60 minutes before and after administration when possible

Storage:

• Refrigerate at 36-46°F (2-8°C) after reconstitution

• Protect from light

• Do not freeze

• Use sterile technique for all withdrawals

Notes:
Tesamorelin is frequently researched for:

• Reduction of visceral fat

• Improved body composition

• Increased IGF-1 levels

• Recovery and tissue repair

• Preservation of lean muscle mass during fat loss

It is commonly stacked with Ipamorelin to enhance growth hormone signaling. A typical combination protocol is:

• Tesamorelin: 2 mg daily

• Ipamorelin: 200-300 mcg daily

For someone in your situation, Matthew, with a focus on reducing abdominal visceral fat while maintaining muscle during a calorie deficit and resistance training, Tesamorelin is one of the more targeted peptides because its strongest human data relates specifically to visceral adipose tissue reduction rather than simply overall weight loss. Most studies show measurable changes emerging after 8-12 weeks, with continued improvements through 6 months of consistent use.